chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Immediately following second dose-body aches, fatigue, dizziness/faintness  Long term changes that may or may not be related but started in the months following vaccination-kidney stones, high blood pressure
(Rt) arm edema, initially swelling of deltoid at site of pneumonia vacc. progressed to swelling at (Rt) elbow & mid portion of (Rt) upper arm. Tender to touch. Flare up of asthma & low grade fever over the weekend, urticaria, tx- ORAPRED.
Patient was sitting in observation area following  vaccine administration when he fainted in his seat. He started sliding down and was unresponsive for a moment according to witness. Pharmacist laid patient down and raised legs, removed coats to make patient more comfortable. Patient re-gained consciousness spontaneously. As patient felt better he was made comfortable , observed longer until he felt confident to leave (refused suggestion to call  for escort). Pharmacist called patient at home to make sure he was feeling good.
Vertigo; Headache; High temperature; Woke up in the morning with vivid nausea and vomiting and threw up constantly; Woke up in the morning with vivid nausea and vomiting and threw up constantly; Body aches; This is a spontaneous report from a contactable consumer (patient). A 70-year-old female patient (weight: 81.65 Kg, height: 173 cm) received BNT162B2 (Pfizer-Biontech covid-19 vaccine, Lot. EL0140) on 21Dec2020, at single dose, for COVID-19 immunisation. Relevant medical history included pulmonary arterial hypertension. Concomitant medications included furosemide (LASIX) 20 mg, daily and potassium 20 meq, daily. The patient experienced the following reactions: body aches on 22Dec2020; nausea and vomiting on 23Dec2020 at 02:00 described as "she woke up in the morning with vivid nausea and vomiting and threw up constantly all on the 23rd and most of the day 24th"; headache and high temperature on 24Dec2020 and vertigo on 25Dec2020. The patient recovered from nausea and vomiting on an unspecified date, in Dec2020, while clinical outcome of the other events was unknown.
13 Weeks Pregnant (3rd pregnancy) at time of shot, due date 2/27/2022.  Started experiencing heart palpitations 3 days after shot. Palpitations became stronger and more frequent within 48 hours I first noticed. No pain or shortness of breath. Contacted provider and was told to monitor them and if they became worse or were accompanied by pain to go to the ER. Also, of note provider mentioned heart palpitations are not uncommon in pregnancy. 3 weeks later still experiencing intermittent palpitations but they have slowed significantly and aren?t nearly as frequent.  Did not have this issue with previous pregnancies (resulting in 2 healthily full term infants).
died from COVID after receiving the two doses of the vaccine; COVID; This is a spontaneous report from a contactable consumer report for a friend. A patient of unspecified age and gender received first dose and second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE) both via an unspecified route of administration on unspecified dates at single doses for covid-19 immunisation. The patient's medical history and concomitant medications were not reported. The consumer mentioned her friend died from COVID after receiving the two doses of the vaccine. The patient died on an unspecified date. It was unknown if an autopsy was performed.  Information on the lot/batch number has been requested.; Reported Cause(s) of Death: died from COVID after receiving the two doses of the vaccine
This spontaneous report as received from a pharmacist refers to a patient of unknown age and gender with no pertinent medical history/drug allergies or drug reactions reported. On an unknown date, the patient was inadvertently vaccinated with an expired dose of PNEUMOVAX23 (lot # J014404 expiration date 22-JAN-2015). There was not concomitant therapy reported. No adverse effect was reported. Additional information has been requested.
Headache, muscles hurt on most of the body, shivering, very very sick feeling and tired.
A nurse reported that a female received an injection of 1985-1986 formula influenza virus vaccine, manufacturer unknown, in 1985 and subsequently developed terrible joint problems. No further information was available at the date of this report.
When the COVID-19 Pfizer shot was administered, the child's arm went dead.  It was sore for a few days. Days after the vaccine, the child symptoms consisted of low grade fever, 101.4, body chills, fatigue, headaches, eyes felt like they were on fire, vomiting and diarrhea. The symptoms came in waves from 11/19/21 through 11/28/21.
Stomach ulcer; Heart burn; This is a spontaneous report from a contactable consumer (patient). A patient of unspecified age and gender received bnt162b2 (BNT162B2 reported as PFIZER COVID 19 VACCINE), dose 1 via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as 1st dose, single dose for covid-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient experienced stomach ulcer and heart burn on an unspecified date. It was reported that the patient got the finally shot couple of days ago and the patient's doctor is closed. The patient had a heartburn and inquired if Gaviscon is gonna interact with the vaccine that the patient took the first dose. The patient paraphrased and reported that "for stomach ulcer, for heart burn." The outcome of the events was unknown.  Information about lot/batch has been requested.
Pfizer-BioNTech COVID-19 Vaccine EUA: patient admitted to hospital one day after vaccination for constipation and abdominal pain. Found to have hydronephrosis and opioid-induced constipation. Urine drained, bowel regimen initiated, and patient discharged to home medically stable.
A puncture vial from 11/13/2021 was not disposed of at the end of the clinic. On 11/14/2021 the RN in charge of drawing up the vaccine used the punctured vial that had been open more than 6 hours to provide a vaccine to a patient. After the dose was administered it was discovered she had used the expired punctured vial. The vial was immediately disposed of. We consulted the CDC's "COVID-19 Vaccine Administration Errors and Deviations" document and were directed to "Contact the manufacturer for information on the stability of the vaccine. If the manufacturer does not have data to support the stability of the vaccine, repeat the dose immediately (no minimum interval).*" After consulting the Janssen website and the Janssen "FACT SHEET FOR HEALTHCARE PROVIDERS ADMINISTERING VACCINE (VACCINATION PROVIDERS)" we were unable to find any information on the stability of punctured vials after 6 hours. We are going to contact the patient to inform them of the error and repeat the dose as per the CDC's recommendations.
I had a pain in my left shoulder blade that made it hard to breathe it was there for about a week or so and then moved to what I think is my left lung area. I never put two and two together till just in the last week. Every time I sneeze, cough, or breath deep or sye it hurts in my upper chest and lower lung area.
Patient developed abdominal pain on the right side on 6/19/21. She was diagnosed with appendicitis and a laparoscopic appendectomy was performed.
fainting; POTS; Dysautonomia; This is a spontaneous report from a contactable consumer (patient). A 40-year-old female patient (non-pregnant at time of vaccination) received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration administered in the left arm on 20Mar2021 (Lot number: EP7534) as single dose for COVID-19 immunisation. Medical history included hypertension and depression, allergies to penicillin. Concomitant medications included fluoxetine hydrochloride (PROZAC), bupropion hydrochloride (WELLBUTRIN), labetalol. The patient previously took the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration administered in the left arm on 02Mar2021 (Lot number: EN6205) as single dose for COVID-19 immunisation. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient did not diagnose with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. Occurred on 29Mar2021, patient experienced dysautonomia: fainting and POTS. The adverse events resulted in Doctor or other healthcare professional office/clinic visit and Emergency room/department or urgent care. The outcome of events was not recovered.
I had the shot on Tuesday, 11/22/16 at approximately 11:00 am. By late afternoon/early evening, I felt my throat swelling as if it was closing and could not swallow and also felt extreme body aches and pin and needles all over. Could not even stand the water from the showered on my skin as it hurt. This was definitely different that pain associated with my fibromyalgia. This continued until the morning of 1/24/16, when it finally started to subside.
Dizziness, Headache, Myalgia, SkinRash, Rash, UrticariaPruritus & Purpura Narrative:  Urgent care; follow up with PCP, Allergist and Dermatologist
Information has been received from a mother concerning her daughter, with no pertinent medical history and no drug reaction/allergies, who on 04-APR-2008 was vaccinated with the first dose of GARDASIL vaccine (yeast) 0.5mL IM, and on 03-APR-2008 was vaccinated with the second dose of GARDASIL vaccine (yeast) 0.5mL IM. There was no concomitant medication. The mother stated that each time her daughter was given GARDASIL vaccine (yeast), she had pain in the back of her shoulder of the arm she got the shot in and it "went down her arm" and she had menstrual cramps. Each time the AE started the day she got the vaccination and she recovered after 2 days. The patient sought unspecified medical attention. Additional information has been requested.
Mistakenly ordered Kinrix when IPOL was not available. Patient was trying to get IPOL before vacation. Through manufacturer it was not indicated that vaccine was age 4-6 and the polio part of vaccination was the same strength as IPOL. Kinrix was mistakenly given when not indicated for patient age.
Patient is fully vaccinated. ED visit for cough, fatigue, syncope.  Patient presents to the emergency department due to fatigue, syncopal episode at home, as well as a cough. Patient states that she was diagnosed with Covid approximately 10 days ago. She states that she has been feeling relatively okay. Denies any recent fevers, nausea or vomiting. She states today she walked over to use the restroom, had lightheadedness, as well as presyncope. She does state that she fell, denies striking her head or complete loss of consciousness.patient was discharged this time. Patient encouraged to continue monitoring her symptoms are worsening shortness of breath or chest pain.
Information was received on 22 January 2008 from a literature article.  A portion of this article is verbatim and is in quotes.  "Thimerosal is a mercury derivative used as a preservative and bacteriostatic agent.  We report an immediate hypersensitivity reaction after skin testing with an adult influenza vaccine that seems to be due to thimerosal.  The patient is a 31-year-old woman with seasonal allergic rhinitis and irritable bowel syndrome.  She developed conjunctival erythema and local pain after using a thimerosal containing contact lens solution 15 years before the evaluation.  She then switched to and tolerated the same brand of contact lens solution without thimerosal.  She received a booster dose of tetanus toxoid (0.05mg of thimerosal per 0.5 mL dose) 2 1/2 years before this evaluation without any difficulty.  Because of her concerns regarding thimerosal, she received a thimerosal-free pediatric influenza vaccine 4 months earlier with no adverse events."  "A skin prick test using the full-strength adult influenza vaccine (25mg of thimerosal per 0.5 mL dose) generated a wheel consisting of a 3-mm induration with 25 mm of erythema with satellite lesions.  Within 20 minutes, the patient developed generalized pruritus without hives, throat tightness, and a dry cough without wheezing on auscultation.  Although her vital signs were stable, she was diffusely pruritic and short of breath.  She was treated with 0.3 mL of epinephrine intramuscularly and 180 mg of fexofenadine orally.  All symptoms resolved within 10 minutes."  The patient returned two months later for a second set of skin prick tests with Pediatric Fluzone vaccine (Thimerosal-free), Tetanus toxoid vaccine (manufacturer Sanofi Pasteur), and Decavac vaccine.  The testing included histamine control and saline glycerol control.  No noteable reaction was observed.  Per the reporter, the patient's reaction was directly observed; and there were no confounding ingestants.  Second, there was documented immediate hypersensitivity reaction to the vaccine containing thimerosal, and lack of a reaction to a similar vaccine without thimerosal.  "Owing to the patient's history of contact sensitivity to thimerosal, the temporal relationship between skin testing with the adult vaccine and the clinically obvious reaction, and the otherwise similar constituents of the adult and pediatric vaccines, we postulate that this reaction was an IgE-mediated immediate hypersensitivity reaction to the thimerosal in the vaccine and that thimerosal probably acts as hapten.  However, this was not formally proved by invitro IgE measurements, and therefore, a non-IgE mechanism is possible."  Per the reporter, it is believed that the patient tolerated earlier exposure to the tetanus vaccine and did not have skin test reactivity to the tetanus vaccine because the dose of thimerosal was much less than in the adult influenza vaccine (0.05 vs 25mg).
It started on 02/17/2021 with tingling on the right side off my face, ear and neck. I am still having all of these same side effects. They aren't as bad but they come and goes. I still feel them at least twice a month. The doctors have ran all types test and have came up with nothing. They did a thyroid and B12 test and they are normal as well.  I Also, I was having some bad menstrual cycle for about fours after the vaccine. It has since became back to normal. Patient stated that she also had COVID arm with dose 1. Patient stated that she has called V-safe and was given the number to the Moderna and I got no answer. No one called or responded and I have really been upset. I am PO with this entire situation. It seems as though no one cares. I work in the healthcare field. I was very surprised when I got this call a year later. I decided to answer the phone this time.
Patient experienced a blister on left foot three (3) days after getting vaccine. Patient felt itchy throughout body and reports eating tomatoes, eggs, acidic food causes the blister to flare up.
Blood clots and blood in urine started approximately 48 hours after receiving the vaccine and lasted on and off for one week. Dr. prescribed Bactrim for 5 days.
Patient called on 4-10-21 at 4:10p to report what she believes to be a delayed hypersensitivity to the vaccine. She got the Janssen Covid-19 vaccine on 4-6-21 at 1:37pm. She said she was fine but 4 days later at the site of injection it was very red, swollen and about 2 inches in diameter. She has been taking Benadryl around the clock and it seems to be helping she just wanted to have  Vaers report filled out just in case. She doesn't believe it serious to require a visit to the emergency room.
Fever; not hungry; tired; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP).  A 10 year-old male patient received bnt162b2 (BNT162B2), administered in arm left, administration date 26Jan2022 15:00 (Lot number: FK8618) at the age of 10 years as dose 2 (tris), single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (Dose: 1, Time: 15.00, Anatomical site of injection: Left arm, Lot Number: FK5618), administration date: 05Jan2022, when the patient was 10 years old, for COVID-19 Immunization. The following information was reported: PYREXIA (non-serious), outcome "recovering", described as "Fever"; DECREASED APPETITE (non-serious), outcome "recovering", described as "not hungry"; FATIGUE (non-serious), outcome "recovering", described as "tired". Relevant laboratory tests and procedures are available in the appropriate section.  Additional information: Vaccination Facility Type was pharmacy or drug store  No follow-up attempts are possible. No further information is expected.
Acute left MCA stroke.  1 week hospitalization at a local Medical Center. 10 days acute rehabilitation at a local Rehab Hospital. Currently, outpatient rehabilitation at another local Hospital.
This case was reported by a physician via call center representative and described the occurrence of injection site pain in a 85-year-old male patient who received SHINGRIX for prophylaxis. On 10th May 2018, the patient received the 2nd dose of SHINGRIX (intramuscular). On 10th May 2018, immediately after receiving SHINGRIX, the patient experienced injection site pain. The patient was treated with TYLENOL. On an unknown date, the outcome of the injection site pain was recovering/resolving. The reporter considered the injection site pain to be almost certainly related to SHINGRIX. Additional details were provided as follows: The physician did not had lot number and expiration. The physician reported that he experienced injection site soreness almost immediately after receiving SHINGRIX. The physician reported that he received TYLENOL which had slightly improved symptom. The physician reported that he was almost certain that it was caused by vaccine.
Patient was asked to wait for 15 minutes post vaccination . Patient needed to use the rest room . He passed out in the restroom . Came to conscious and informed staff that he passed out . This happened within 5 to 10 minutes of receiving  vaccination.He was pale . Offered ice pack and water . Patient started sweating profusely . Patient said his head/neck  was hurting. ( May have hit head ).BP when checked by RPh showed 150/85 HR 81. All vitals were stable when EMS arrives. Patient did not go to hospital.
Information has been received concerning a pt who has a history of varicella exposure, was vaccinated on 05/30/00 with one dose of varicella vaccine. On 06/08/00 the pt developed generalized vesicular lesions. Additionally, it was noted that the pt's sister experienced a similar reaction. On 06/09/00 two swab specimens were obtained for VZV identification, however the specimens were inadequate to process.
Myalgia & Fever Narrative:  fever of 102 F lasted 18 hours, myalgia last about 24 hours  Other Relevant History:
got the vaccine got shingles / suspected vaccination failure; shingles; This case was reported by a consumer via interactive digital media and described the occurrence of suspected vaccination failure in a male patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.  Additional case details were reported as follows: The reporter was patient's wife. The age at vaccination was not reported. The patient got the vaccine and still got shingles. This case was considered as suspected vaccination failure, as details regarding completion of primary vaccination schedule, laboratory test confirmation and time to onset for shingles were unknown at the time of reporting. The follow up was not required.
After immunization given patient was crying for approximately 3 minutes. Patient stopped crying while looking for a sticker found one stepped away for his siblings to take stickers and became pale and passed out. Patient hit is head on the ground.  Patient came to and we placed him on an exam table gave him orange juice and crackers and placed a cold pack behind his neck. Patient was examined by provider and found no injuries.
Information has been received from an individual in a physician's office concerning a 13 year old white female who on 21 Oct 1996 at 1:00 pm was vaccinated in the left arm with a first dose of Varivax. There was no illness at the time of vaccination. On 24 mar 2006, the patient had less then 50 lesions. "No adverse effects" were reported. No medical attention was sought. Additional information is not expected.
Fever ranging from 100 to 103, chills, muscle aches for four days. Took ibuprofen. Did not see physician. Staring to feel better today (afternoon of fourth day) but still has temperature.
Severe muscle cramping and joint pain first in right leg x 3months then in right leg x 1 month and ongoing.
had to two shots year / One didn't end it, the next year I got shingles againg / that took care of them \ suspected vaccination failure; next year I got shingles againg / that took care of them; This case was reported by a consumer via interactive digital media and described the occurrence of suspected vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   Co-suspect products included Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingles vaccine and the 2nd dose of Shingles vaccine. On an unknown date, less than 2 years after receiving Shingles vaccine and Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. The action taken with Shingles vaccine was unknown. On an unknown date, the outcome of the vaccination failure and shingles were unknown.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine and Shingles vaccine.  Additional details were provided as follows: This case was reported by patient himself/herself. The age at vaccination was not reported. The patient stated he/she had two shingles shots year and one did not end it, the next year the patient got shingles again and that took care of them for good. The follow-up would not possible as no contact details were available. This case was considered as suspected vaccination failure, since the details regarding the laboratory confirmation were not provided.
Patient received a bivalent booster from clinic on 10/25/22 and a bivalent booster from Pharmacy on 11/08/22.
Patient receives FLUVIRIN flu shot. She said was not as bad as she thought. I told her to sit then she fainted sitting in chair then fell on floor. I proceed to do CPR but she became conscious and talking. She was not itching and no hives. Call 911. EMT's came took vitals and took her to hospital.
Pounding headache, lethargic, exhaustion, arms was tremendously sore.  These symptoms lasted 48 hours.  I did not experience this with my first two Pfizer Covid vaccine shots.
Acute swelling and erythema left upper thigh with fever. Information from missing data report states: sudden onset shortly after vaccine was given.
Information has been received from a medical assistant, on 02-JUL-2015, concerning a patient of unknown age and gender. On 24-JUN-2015, the patient was vaccinated with a dose of PEDVAXHIB (lot # K008878) 0.5 ml (expiration date, route and site of administration were not reported) that underwent 159 hours temperature excursion. No adverse effects had been observed or reported. This is one of several reports from the same reporter. Additional information has been requested.